Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElixirr International Regulatory News (ELIX)

Share Price Information for Elixirr International (ELIX)

Share Price is delayed by 15 minutes
Get Live Data
700.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (0.857%)
Market Cap: £346.93m
ELIX Live PriceLast checked at - London Stock Exchange

Intraday Elixirr International Share Chart

Director Declaration

21 May 2024 18:20

RNS Number : 3547P
Elixirr International PLC
21 May 2024
 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

Director Declaration

 

Elixirr International plc (AIM:ELIX), the established, global award-winning challenger consultancy, has been notified by Simon Retter, Non-Executive Director of the Company, that Horizonte Minerals plc, a company of which he was a Director until 25 November 2023, entered administration on 16 May 2024.

This announcement is made in accordance with AIM Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

For further information please contact:

Elixirr International plc

Stephen Newton, CEO

Graham Busby, CFO

 

 

 

 

Public and Investor Relations contacts:

investor-relations@elixirr.com 

 

Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker)

Stephen Keys, Charlie Beeson (Corporate Finance)

Sunila de Silva (Corporate Broking)

 

Investec Bank plc (Joint Broker)

Carlton Nelson, Henry Reast (Corporate Broking)

 

 

 

 

 

+44 (0) 20 7220 0500

 

 

+44 (0) 20 7597 4000

 

 

About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNMZGZKVMNGDZM
Date   Source Headline
13th Jun 20221:00 pmRNSResult of AGM
19th May 20227:00 amRNSPosting of Annual Report & Accounts
29th Apr 20224:07 pmRNSResult of Secondary Placing
28th Apr 20224:06 pmRNSProposed Secondary Placing
8th Apr 20224:15 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSAcquisition of iOLAP and FY2022 Earnings
1st Feb 20227:00 amRNSTrading Update
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 202111:41 amRNSResult of Secondary Placing
13th Oct 20217:00 amRNSProposed Secondary Placing
27th Sep 20217:00 amRNSInterim Results
17th Jun 20218:13 amRNSDirector/PDMR Shareholding
16th Jun 202112:21 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
24th May 20217:00 amRNSPosting of Annual Report & Notice of AGM
12th May 20213:52 pmRNSResult of Secondary Placing
12th May 20212:09 pmRNSProposed Secondary Placing
30th Apr 20214:15 pmRNSResult of General Meeting
27th Apr 20214:12 pmRNSGrant of Share Options
14th Apr 20217:00 amRNSCircular and Notice of GM
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20212:06 pmRNSSecond Price Monitoring Extn
13th Apr 20212:01 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSAcquisition of Retearn Group Limited
12th Apr 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSDirector/PCA Dealings
8th Feb 20218:00 amRNSTrading Update
21st Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20208:00 amRNSHolding(s) in Company
17th Dec 20207:00 amRNSHolding(s) in Company
16th Dec 20207:00 amRNSHolding(s) in Company
11th Dec 20207:00 amRNSResult of Secondary Placing
10th Dec 20203:57 pmRNSProposed Secondary Placing
13th Nov 20207:00 amRNSPDMR Dealing
2nd Nov 20202:05 pmRNSPDMR Dealing
29th Oct 20207:00 amRNSAcquisition of Coast Digital Limited
19th Oct 20207:00 amRNSTrading Update
15th Sep 20207:00 amRNSInterim Results
11th Aug 20207:00 amRNSPCA Shareholding
27th Jul 20207:00 amRNSPDMR Dealing
22nd Jul 20207:00 amRNSPCA Dealing
14th Jul 20205:15 pmRNSHolding(s) in Company
9th Jul 20208:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.